A clinical trial led by researchers in the University of Oxford\u2019s Radcliffe Department of Medicine and Oxford Population Health, has found that while a structured weight-loss programme helped older adults with atrial fibrillation (AF) shed weight safely and sustainably, it did not improve their heart rhythm symptoms or reduce the need for further treatment.
On 28 August, RDM signed a Memorandum of Understanding with the National Defense Medical University and Tri-Service General Hospital in Taiwan which will provide funding for their students who have successfully enrolled on the DPhil in Medical Sciences.
Earlier this year, a group of researchers from the MRC Weatherall Institute of Molecular Medicine attended the Big Bang Fair in Birmingham, showcasing medical research through a series of hands-on activities.
A team led by scientists at the University of Oxford and the Leibniz-Forschungsinstitut f\u00fcr Molekulare Pharmakologie in Berlin has used fluorescent versions of next-generation diabetes and obesity drugs to reveal, for the first time, exactly which cells they target in the pancreas and brain.
Study led by Psaila Group uncovers previously unknown function of platelets as DNA \u2018vacuum cleaners\u2019 in the blood, with profound implications for cancer diagnosis and prenatal screening.
Claus Nerlov, Professor of Stem Cell Biology, has been awarded funding from Wellcome to map the gene regulatory networks in blood cell production and seek new therapeutic targets.
The latest study from researchers in the MRC Translational Immune Discovery Unit in the MRC Weatherall Institute of Molecular Medicine has been published in Cell Reports Medicine.
A new study from scientists at the Radcliffe Department of Medicine and Harvard Medical School, and funded by the British Heart Foundation, has uncovered a potential new treatment for hypertrophic cardiomyopathy (HCM).
A new spinout company, formed from research conducted at the MRC Translational Immune Discovery Unit, aims to develop a new class of therapies for patients with inflammatory bowel disease.
Researchers at the MRC Weatherall Institute of Molecular Medicine and the German Cancer Research Center (DKFZ) have developed a new method to analyse how our tissues evolve as we age.
The MRC Weatherall Institute of Molecular Medicine (WIMM) community gathered for its flagship annual event, WIMM Day, on Tuesday 24 June. Held at the Sa\u00efd Business School, the day showcased the breadth and impact of research across the institute and celebrated achievements in mentorship, public engagement and more.
On 30 June Professor Sten Eirik W. Jacobsen is retiring after 19 years as the Bass Professor of Developmental and Stem Cell Biology at the University of Oxford. His work has unravelled novel insights into normal and malignant haematopoietic stem and progenitor cell biology.
In the UK more than 4.3 million people live with Type-2 Diabetes, and 2.4 million more are at increased risk of developing the disease. Type-2 Diabetes, obesity, hypertension, and fatty liver disease frequently cluster together in the same individuals. It is becoming clear that sleep and body clock problems have a role to play in this \u2018cardiometabolic multimorbidity\u2019, but its exact nature is under-researched.
The Academy of Medical Sciences has elected five University of Oxford biomedical and health scientists to its fellowship in 2025, including Charis Antoniades.
![\"A](\"https://www.rdm.ox.ac.uk/news/weight-loss-alone-doesn2019t-ease-atrial-fibrillation-symptoms-in-older-adults-study-finds/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n